Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
about
Sp7/Osterix Is Restricted to Bone-Forming Vertebrates where It Acts as a Dlx Co-factor in Osteoblast Specification.Molecular control of nitric oxide synthesis through eNOS and caveolin-1 interaction regulates osteogenic differentiation of adipose-derived stem cells by modulation of Wnt/β-catenin signaling.MicroRNAs in Bone Balance and Osteoporosis.p53 inhibits SP7/Osterix activity in the transcriptional program of osteoblast differentiation.Distinct DNA methylation profiles in bone and blood of osteoporotic and healthy postmenopausal women.Osteogenic Factor Runx2 Marks a Subset of Leptin Receptor-Positive Cells that Sit Atop the Bone Marrow Stromal Cell Hierarchy.Regulation of Cartilage Development and Diseases by Transcription Factors.mTOR/Raptor signaling is critical for skeletogenesis in mice through the regulation of Runx2 expression.Collagen-derived dipeptide prolyl-hydroxyproline promotes osteogenic differentiation through Foxg1.Transcriptional network systems in cartilage development and disease.Study of the osteogenesis effect of icariside II and icaritin on canine bone marrow mesenchymal stem cells.RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN.Cbfb2 Isoform Dominates More Potent Cbfb1 and Is Required for Skeletal Development.Roles of Runx2 in Skeletal Development.Identification of the gene-regulatory landscape in skeletal development and potential links to skeletal regeneration
P2860
Q37135811-EE936AEC-04DD-4C8C-9F41-4C9ECB9A2074Q37481098-ACA77422-8730-4952-9312-BABB6487E885Q38556136-42CAD049-64BA-4D6D-AF45-95D61CF98B1CQ38640975-A6A157AF-1C06-477E-8764-389C0AD9B8F1Q38709236-6557FD77-4976-491B-AA22-C9812F8C857FQ40973746-4956B4EE-50BB-4B88-999D-E7E75E8C078BQ41685459-63D0DCDB-7D3C-4FFF-88E5-D07960F0FF6CQ42706139-08F4EAD8-1434-4398-8055-FF80EDA39BD1Q47110857-C49B9999-25AB-4308-BA6F-A7E8F680CCFDQ47225671-BF92769B-1A28-4E44-9541-842CB8AE3F7DQ47267512-77BA6480-E719-4247-97B9-7E97B0DBD621Q47692014-28B6DF10-10C1-414E-908E-ADD95BF3CA7EQ50532624-20D9587C-8066-46B8-AD54-EF6C016DD824Q51097637-EC68E985-3381-4D89-B37A-6BB18EA42E95Q57153455-4BC2EE1C-3210-4242-B3DF-96636B26E717
P2860
Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
@en
Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
@nl
type
label
Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
@en
Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
@nl
prefLabel
Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
@en
Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
@nl
P2093
P2860
P356
P1476
Dlx5 and mef2 regulate a novel runx2 enhancer for osteoblast-specific expression.
@en
P2093
Hisato Komori
Masako Mori
Qing Jiang
Riko Nishimura
Shinichi Izumi
Takeshi Moriishi
Tetsuya Kawane
Toshihiro Miyazaki
Toshihisa Komori
Wenguang Liu
P2860
P304
P356
10.1002/JBMR.2240
P577
2014-09-01T00:00:00Z